1. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume
   Markus Bookland et al, 2018, Acta Neurochir CrossRef
2. MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions
   Alessandro Leonetti et al, 2018, Drug Resistance Updates CrossRef
3. microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
   Ning Wang et al, 2018, Cancers CrossRef
4. Apoptotic suppression of inflammatory macrophages and foam cells in vascular tissue by miR-23a
   Rabih Roufayel et al, 2019, Health Technol. CrossRef
5. Inhibition of long noncoding RNA growth arrest–specific 5 attenuates cerebral injury induced by deep hypothermic circulatory arrest in rats
   Shilun Gao et al, 2019, The Journal of Thoracic and Cardiovascular Surgery CrossRef
6. The Roles of MicroRNA in Lung Cancer
   Kuan-Li Wu et al, 2019, IJMS CrossRef
7. Interactive functions of microRNAs in the miR‐23a‐27a‐24‐2 cluster and the potential for targeted therapy in cancer
   Mengying Cui et al, 2019, J Cell Physiol CrossRef
8. AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/−SMA model mice
   Kevin A Kaifer et al, 2019 CrossRef
9. PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
   Francesca Luongo et al, 2019, Cancers CrossRef
10. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
    null Khan et al, 2019, Cells CrossRef
11. Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
    Yoojung Kwon et al, 2019, Cancers CrossRef
12. The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
    Roberta Roncarati et al, 2019, Front. Oncol. CrossRef
13. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN
    Sakir Akgun et al, 2019, ACAMC CrossRef
14. miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
    Peng Ge et al, 2019, BMC Cancer CrossRef
15. MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation response in mice
    Zhikun Li et al, 2019, Cell Cycle CrossRef
16. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.
    Min Yuan et al, 2019, Signal Transduct Target Ther CrossRef
17. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a
    Huilong Lin et al, 2020, Biomedicine & Pharmacotherapy CrossRef
18. MicroRNA-23a suppresses the apoptosis of inflammatory macrophages and foam cells in atherogenesis by targeting HSP90
    Yu Qiao et al, 2019, Gene CrossRef
19. Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.
    Stefan Hatzl et al, 2020, Cancers (Basel) CrossRef
20. Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN
    Jiang Du et al, 2020, Front. Oncol. CrossRef
21. Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment.
    Hang fai Kwok, 0 CrossRef
22. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
    Yingbing Zhang et al, 2019, Int J Mol Med CrossRef
23. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway
    Gang Huang et al, 2019, Aging CrossRef
24. Targeting Akt-associated microRNAs for cancer therapeutics
    Mir S. Adil et al, 2020, Biochemical Pharmacology CrossRef
25. Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
    Asal Jalal Abadi et al, 2021, Biomolecules CrossRef
26. Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
    Jolanta Kryczka et al, 2021, Diagnostics CrossRef
27. HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial-mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation.
    Wei Tian et al, 2021, Acta Pharm Sin B CrossRef
28. Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers
    Ke Li et al, 2021, Front. Cell Dev. Biol. CrossRef
29. Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
    Sarah E. Mudra et al, 2021, Cancers CrossRef
30. MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
    Amirhosein Maharati et al, 2022, Cell Commun Signal CrossRef
31. Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
    Xunxun Zhu et al, 2022, Bioengineered CrossRef
32. The molecular mechanism of circRHOBTB3 inhibits the proliferation and invasion of epithelial ovarian cancer by serving as the ceRNA of miR-23a-3p
    Yihan Fu et al, 2022, J Ovarian Res CrossRef
33. Emerging strategies to overcome resistance to third-generation EGFR inhibitors
    Kunyu Shi et al, 2022, J Hematol Oncol CrossRef
34. Panoramic view of microRNAs in regulating cancer stem cells
    Yongzhi Zhao et al, 2022 CrossRef
35. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.
    Jun Sheng et al, 2021, J Chemother CrossRef
36. Role of Non-Coding RNAs in Lung Cancer
    Maksat Babayev et al, 2022 CrossRef
37. Morphine-mediated release of astrocyte-derived extracellular vesicle miR-23a induces loss of pericyte coverage at the blood-brain barrier: Implications for neuroinflammation
    Ke Liao et al, 2022, Front. Cell Dev. Biol. CrossRef
38. Overcoming acquired resistance to EGFR-targeted therapy by regulating autophagy
    Kewen Qian et al, 2023 CrossRef
39. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
    Hanie Abolfathi et al, 2023, Respir Res CrossRef
40. Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer
    Yanting Wang et al, 2023, Front. Oncol. CrossRef
41. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications
    Ritu Shekhar et al, 2024 CrossRef
42. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance
    Di Wu et al, 2024, Biochemical Pharmacology CrossRef
43. Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.
    Sarah Sayed Hassanein et al, 2021, Int J Mol Sci CrossRef
44. Clinical applications of circulating biomarkers in non-small cell lung cancer
    Hyun-Ji Oh et al, 2024, Front. Cell Dev. Biol. CrossRef
45. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors
    Qiangfeng Wang et al, 2024, Future Medicinal Chemistry CrossRef
46. Roles of miRNAs in regulating ovarian cancer stemness
    Zhi-Xiong Chong, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
47. The 4EHP-mediated translational repression of cGAS impedes the host immune response against DNA viruses
    Reese Jalal Ladak et al, 2024, Proc. Natl. Acad. Sci. U.S.A. CrossRef